David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 8,000 shares at $2.17 ($18K) on 2011-12-13, disclosed to the SEC on 2011-12-14.
Open-market purchase of $18k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.14 | 1,000 | $2K | 12.2% |
| 2 | $2.15 | 1,000 | $2K | 12.3% |
| 3 | $2.17 | 1,000 | $2K | 12.4% |
| 4 | $2.18 | 1,000 | $2K | 12.5% |
| 5 | $2.21 | 2,000 | $4K | 25.3% |
| 6 | $2.22 | 2,000 |
| $4K |
| 25.4% |
| Total | $2.19 avg | 8,000 | $18K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |